Patents by Inventor Eugene Roussel

Eugene Roussel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic modulation of the tumor inflammatory response
    Patent number: 7871630
    Abstract: The invention relates to compositions, kits, and methods for alleviating cancer (i.e., a tumor) in a human patient. The therapeutic modality effected by the invention involves inducing a type 1 inflammatory response in the tumor tissue, whereby the tumor tissue is diminished or destroyed and the patient develops immune memory that inhibits or prevents recurrence of the tumor.
    Type: Grant
    Filed: June 9, 2005
    Date of Patent: January 18, 2011
    Assignee: BioTHER Corporation
    Inventor: Eugene Roussel
  • Therapeutic modulation of the tumor inflammatory response
    Patent number: 7041302
    Abstract: The invention relates to compositions, kits, and methods for alleviating cancer (i.e., a tumor) in a human patient. The therapeutic modality effected by the invention involves inducing a type 1 inflammatory response in the tumor tissue, whereby the tumor tissue is diminished or destroyed and the patient develops immune memory that inhibits or prevents recurrence of the tumor.
    Type: Grant
    Filed: January 9, 2001
    Date of Patent: May 9, 2006
    Assignee: BioTHER Corporation
    Inventor: Eugene Roussel
  • Therapeutic modulation of the tumor inflammatory response
    Publication number: 20050276786
    Abstract: The invention relates to compositions, kits, and methods for alleviating cancer (i.e., a tumor) in a human patient. The therapeutic modality effected by the invention involves inducing a type 1 inflammatory response in the tumor tissue, whereby the tumor tissue is diminished or destroyed and the patient develops immune memory that inhibits or prevents recurrence of the tumor.
    Type: Application
    Filed: June 9, 2005
    Publication date: December 15, 2005
    Applicant: Biother Corporation
    Inventor: Eugene Roussel
  • Therapeutic modulation of the tumor inflammatory response
    Publication number: 20020090353
    Abstract: The invention relates to compositions, kits, and methods for alleviating cancer (i.e., a tumor) in a human patient. The therapeutic modality effected by the invention involves inducing a type 1 inflammatory response in the tumor tissue, whereby the tumor tissue is diminished or destroyed and the patient develops immune memory that inhibits or prevents recurrence of the tumor.
    Type: Application
    Filed: January 9, 2001
    Publication date: July 11, 2002
    Inventor: Eugene Roussel